Relevance of Biologically Equivalent Dose Values in Outcome Evaluation of Stereotactic Radiotherapy for Lung Nodules

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1, 2008, Pages 145-151

  Casamassima, Franco ^a   Masi, Laura ^a   Bonucci, Ivano ^a   Polli, Caterina ^a   Menichelli, Claudia ^a   Gulisano, Massimo ^a   Pacini, Stefania ^a   Aterini, Stefano ^a,b   Cavedon, Carlo ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MISERICORDIA E DOLCE HOSPITAL   (Italy)

^c Vicenza Hospital   (Italy)

Author keywords

Biologically equivalent dose; Lung nodules; Stereotactic radiotherapy

Indexed keywords

DRUG DOSAGE; ONCOLOGY; TISSUE;

LUNG NODULES; STEREOTACTIC RADIOTHERAPY;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; BIOLOGICALLY EQUIVALENT DOSE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; STEREOTACTIC RADIOSURGERY; TREATMENT RESPONSE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COIN LESION, PULMONARY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; RADIOSURGERY; RELATIVE BIOLOGICAL EFFECTIVENESS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41749118688     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.09.036     Document Type: Article

References (33)

1. Jeremic B., Classen J., and Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
2. Blomgren H., Lax I., Näslund I., et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Acta Oncol 34 (1995) 861-870
3. Herfarth K.K., Debus J., Lohr F., et al. Extracranial stereotactic radiation therapy: Setup accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 46 (2000) 329-335
4. Wulf J., Hädinger U., Oppitz U., et al. Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 57 (2000) 225-236
5. Negoro Y., Nagata Y., Aoki T., et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: Reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys 50 (2001) 889-898
6. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients. Cancer 82 (1998) 1062-1070
7. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 (2003) 126-135
8. Liu L., Bassano D.A., Prasad S.C., et al. The linear-quadratic model and fractionated stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 827-832
9. Wulf J., Hädinger U., Oppitz U., et al. Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver. Radiother Oncol 66 (2003) 141-150
10. Sohaib S.A., Turner B., Hanson J.A., et al. CT assessment of tumour response to treatment: Comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol 73 (2000) 1178-1184
11. Jaffe C.C. Measures of response: RACIST, WHO, and new alternatives. J Clin Oncol 24 (2006) 3245-3251
12. Thomlinson R.H., and Gray L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9 (1955) 539-549
13. Zywietz F., Hahn L.S., and Lierse W. Ultrastructural studies on tumor capillaries of a rat rhabdomyosarcoma during fractionated radiotherapy. Acta Anat (Basel) 150 (1994) 80-85
14. Ng Q.S., Goth V., Milner J., et al. Acute tumor vascular effect following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 67 (2007) 417-424
15. Garcia-Barros M., Paris F., Cordon-Cardo C., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (2003) 1155-1159
16. Acker J.C., Marks L.B., Spencer D.P., et al. Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation. Radiat Res 149 (1998) 350-359
17. Rodemann H.P., and Blaese M.A. Responses of normal cells to ionizing radiation. Semin Radiat Oncol 17 (2007) 81-88
18. Pena L.A., Fuks Z., and Kolesnick R.N. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60 (2000) 321-327
19. Hazuka M.B., Turrisi III A.T., Lutz S.T., et al. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis. Int J Radiat Oncol Biol Phys 27 (1993) 273-284
20. Nakagawa K., Aoki Y., Tago M., et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: Original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 48 (2000) 449-457
21. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
22. Lee S., Choi E., Park H., et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40 (2003) 309-315
23. Uematsu M., Shioda M., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
24. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
25. Timmerman R., McGarry R., Papiez L., et al. Initial report of a prospective phase II trial of stereotactic body radiation therapy for patients with medically inoperable stage I non-small cell lung cancer. [Abstract]. Int J Radiat Oncol Biol Phys 63 Suppl. (2005) S99
26. Wulf J., Hädinger U., Oppitz U., et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A non invasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
27. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
28. Willner J., Baier K., Caragiani E., et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52 (2002) 382-389
29. Martel M., Ten Haken R., Hazuka M., et al. Estimation of tumor control probability from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
30. Belderbos J., De Jaeger K., Heemsbergen W., et al. First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Radiother Oncol 66 (2003) 119-126
31. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a Phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
32. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
33. Wulf J., Baier K., Mueller G., et al. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 77 (2005) 83-87